These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Antihypertensive drug prescription trends at the primary health care centres in Bahrain. Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335 [TBL] [Abstract][Full Text] [Related]
46. [Antihypertensive treatment with nitrendipine]. Nalin G; Beghelli G Minerva Cardioangiol; 1996; 44(1-2):67-72. PubMed ID: 8767626 [TBL] [Abstract][Full Text] [Related]
47. [Neurovegetative inhibition as a component of general anesthesia]. Darbinian TM; Baranova LM; Grigor'iants RG; Iarustovskiĭ MB Anesteziol Reanimatol; 1983; (2):3-9. PubMed ID: 6688161 [No Abstract] [Full Text] [Related]
48. Can propranolol be a viable option for the treatment of small-for-size syndrome? Yu YD; Kim DS; Byun GY; Seo SO Liver Transpl; 2012 Jun; 18(6):747-8. PubMed ID: 22359396 [No Abstract] [Full Text] [Related]
49. [Open pilot study of the activity and tolerability of cadralazine in hypertensive patients resistant to other therapy]. Angelino PF; Bensoni M; Gastaldo D; Minelli M; Parini M; Lavezzaro GC Minerva Cardioangiol; 1982 Mar; 30(3):69-74. PubMed ID: 7088296 [No Abstract] [Full Text] [Related]
50. [Propranolol in the therapy of infantile hemangioma--fascinating, but not with risk]. Fölster-Holst R J Dtsch Dermatol Ges; 2010 Mar; 8(3):149-50. PubMed ID: 20406338 [No Abstract] [Full Text] [Related]
51. Emergency or urgency? Effective management of hypertensive crises. Kuppasani K; Reddi AS JAAPA; 2010 Aug; 23(8):44-9. PubMed ID: 20821913 [No Abstract] [Full Text] [Related]
53. [Vasodilators in the therapy of systemic arterial hypertension. Review of the literature and personal contributions]. Lavezzaro GC; Buraglio M; Angelino PF Minerva Cardioangiol; 1982 Sep; 30(9):427-36. PubMed ID: 7155376 [No Abstract] [Full Text] [Related]
54. [Hypertensive crises (a review of the literature)]. Grigorovich VD Vrach Delo; 1990 Feb; (2):2-7. PubMed ID: 2187305 [No Abstract] [Full Text] [Related]
55. [Avlocardyl]. De Longraye J; Gervais C Soins; 1982 Feb; 27(4):43-5. PubMed ID: 6918148 [No Abstract] [Full Text] [Related]
56. [Combined use of alpha- and beta-adrenergic blockers with vasodilators in hypertensive crises]. Plastinina RA; Logacheva IV; Barenbaum ES; Nikolaeva VA; Polishchuk MA Sov Med; 1982; (10):108-10. PubMed ID: 7178954 [No Abstract] [Full Text] [Related]
57. [Treatment of hypertension with a combination of the adrenergic beta receptor blockader, obsidan, and the vasodilator, apressin]. Erina EV; Ozokvo GI; Lediashova GA Ter Arkh; 1978; 50(11):112-7. PubMed ID: 725752 [No Abstract] [Full Text] [Related]
58. Combined treatment of hypertension with vasodilatation and beta-adrenergic blockade. Hansson L; Zweifler AJ Mich Med; 1973 Oct; 72(30):695-8. PubMed ID: 4147721 [No Abstract] [Full Text] [Related]
59. Beta-adrenergic blockers in the treatment of hypertension--experience with propranolol at Ibadan, Nigeria. Olatunde A; Akinkugbe OO; Carlisle R East Afr Med J; 1977 Apr; 54(4):194-201. PubMed ID: 902626 [No Abstract] [Full Text] [Related]
60. [Fixed-dose combination therapy: reduction of side effects with enhanced tolerance and antihypertensive efficacy]. González Maqueda I; Gómez Guindal JA; González Lama I Rev Esp Cardiol; 1999; 52 Suppl 3():59-72. PubMed ID: 10614151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]